Medicare Data Utilities Appendices

93510-93529); MULTIPLE STUDIES, REST OR STRESS (EXERCISE AND/OR PHARMACOLOGIC)
G0038 PET MYOCARDIAL PERFUSION IMAGING, (FOLLOWING STRESS PLANAR MYOCARDIAL
PERFUSION, 78460); SINGLE STUDY, REST OR STRESS (EXERCISE AND/OR PHARMACOLOGIC)
G0039 PET MYOCARDIAL PERFUSION IMAGING, (FOLLOWING STRESS PLANAR MYOCARDIAL
PERFUSION, 78460); MULTIPLE STUDIES, REST OR STRESS (EXERCISE AND/OR
PHARMACOLOGIC)
G0040 PET MYOCARDIAL PERFUSION IMAGING, (FOLLOWING STRESS ECHOCARDIOGRAM, 93350);
SINGLE STUDY, REST OR STRESS (EXERCISE AND/OR PHARMACOLOGIC)
G0041 PET MYOCARDIAL PERFUSION IMAGING, (FOLLOWING STRESS ECHOCARDIOGRAM, 93350);
MULTIPLE STUDIES, REST OR STRESS (EXERCISE AND/OR PHARMACOLOGIC)
G0042 PET MYOCARDIAL PERFUSION IMAGING, (FOLLOWING STRESS NUCLEAR VENTRICULOGRAM,
78481 OR 78483); SINGLE STUDY, REST OR STRESS (EXERCISE AND/OR PHARMACOLOGIC)
G0043 PET MYOCARDIAL PERFUSION IMAGING, (FOLLOWING STRESS NUCLEAR VENTRICULOGRAM,
78481 OR 78483); MULTIPLE STUDIES, REST OR STRESS (EXERCISE AND/OR
PHARMACOLOGIC)
G0044 PET MYOCARDIAL PERFUSION IMAGING, (FOLLOWING REST ECG, 93000); SINGLE STUDY,
REST OR STRESS (EXERCISE AND/OR PHARMACOLOGIC)
G0045 PET MYOCARDIAL PERFUSION IMAGING, (FOLLOWING REST ECG, 93000); MULTIPLE
STUDIES, REST OR STRESS (EXERCISE AND/OR PHARMACOLOGIC)
G0046 PET MYOCARDIAL PERFUSION IMAGING, (FOLLOWING STRESS ECG, 93015); SINGLE STUDY,
REST OR STRESS (EXERCISE AND/OR PHARMACOLOGIC)
G0047 PET MYOCARDIAL PERFUSION IMAGING, (FOLLOWING STRESS ECG, 93015); MULTIPLE
STUDIES, REST OR STRESS (EXERCISE AND/OR PHARMACOLOGIC)
G0050 MEASUREMENT OF POST-VOIDING RESIDUAL URINE AND/OR BLADDER CAPACITY BY
ULTRASOUND
G0051 DESTRUCTION BY ANY METHOD, INCLUDING LASER, WITH OR WITHOUT SURGICAL
CURETTEMENT OF ALL BENIGN OR PREMALIGNANT LESIONS (E.G. ACTINIC KERATOSIS),
OTHER THAN SKIN TAGS OR CUTANEOUS VASCULAR PROLIFERATIVE LESIONS, INCLUDING
LOCAL ANESTHESIA; INITIAL LESION
G0052 DESTRUCTION BY ANY METHOD, INCLUDING LASER, WITH OR WITHOUT SURGICAL
CURETTEMENT OF ALL BENIGN OR PREMALIGNANT LESIONS (E.G. ACTINIC KERATOSIS),
OTHER THAN SKIN TAGS OR CUTANEOUS VASCULAR PROLIFERATIVE LESIONS, INCLUDING
LOCAL ANESTHESIA; SECOND THROUGH 14 LESIONS, EACH (G0051 PLUS G0052 EQUAL 14
LESIONS)
G0053 DESTRUCTION BY ANY METHOD, INCLUDING LASER, WITH OR WITHOUT SURGICAL
CURETTEMENT OF ALL BENIGN OR PREMALIGNANT LESIONS (E.G. ACTINIC KERATOSIS),
OTHER THAN SKIN TAGS OR CUTANEOUS VASCULAR PROLIFERATIVE LESIONS, INCLUDING
LOCAL ANESTHESIA; 15 LESIONS OR MORE (INCLUDES G0051 AND G0052; THAT IS, G0053
MAY NOT BE REPORTED IN ADDITION TO G0051 AND G0052)
G0058 AUTOMATED MULTICHANNEL TEST; 20 CLINICAL CHEMISTRY TESTS
G0059 AUTOMATED MULTICHANNEL TEST; 21 CLINICAL CHEMISTRY TESTS
G0060 AUTOMATED MULTICHANNEL TEST, 22 CLINICAL CHEMISTRY TESTS
G0062 PERIPHERAL SKELETAL BONE MINERAL DENSITY STUDIES (E.G., RADIUS, WRIST, HEEL).
G0063 CENTRAL SKELETAL BONE MINERAL DENSITY STUDIES (E.G., SPINE, PELVIS).
G0064 PHYSICIAN SUPERVISION OF A PATIENT UNDER CARE OF A HOME HEALTH AGENCY (PATIENT
NOT PRESENT) REQUIRING COMPLEX AND MULTIDISCIPLINARY CARE MODALITIES INVOLVING
REGULAR PHYSICIAN DEVELOPMENT AND/OR REVISION OF CARE PLANS, REVIEW OF
SUBSEQUENT REPORTS OF PATIENT STATUS, REVIEW OF RELATED LABORATORY AND OTHER
STUDIES, COMMUNICATION (INCLUDING TELEPHONE CALLS) WITH OTHER HEALTH CARE
PROFESSIONALS INVOLVED IN PATIENT'S CARE, INTEGRATION OF NEW INFORMATION INTO
THE MEDICAL TREATMENT PLAN AND/OR ADJUSTMENT OF MEDICAL THERAPY, WITHIN A
CALENDAR MONTH; 30 MINUTES OR MORE.
G0065 PHYSICIAN SUPERVISION OF A HOSPICE PATIENT (PATIENT NOT PRESENT) REQUIRING
COMPLEX AND MULTIDISCIPLINARY CARE MODALITIES INVOLVING REGULAR PHYSICIAN
DEVELOPMENT AND/OR REVISION OF CARE PLANS, REVIEW OF SUBSEQUENT REPORTS OF
PATIENT STATUS, REVIEW OF RELATED LABORATORY AND OTHER STUDIES, COMMUNICATION
(INCLUDING TELEPHONE CALLS) WITH OTHER HEALTH CARE PROFESSIONALS INVOLVED IN